Curcumin C3 Complex® Subject of New Control Trial

April 26, 2010

1 Min Read
Curcumin C3 Complex® Subject of New Control Trial

EAST WINDSOR, N.J.Curcumin, derived from the spice turmeric (curry powder), is a major staple in Indian lifestyle and has been shown to suppress survival, proliferation, invasion, angiogenesis and metastasis of colon cancer cells. The potential role of curcumin as a therapeutic intervention warrants further investigation, and has prompted the St. George Hospital to commence a double blind, randomized, control trial using higher dosages of Sabinsas Curcumin C3 Complex® in a larger cohort of patients.

Curcumin C3 Complex has been the subject of many studies including, Curcumin and colorectal cancer: Add spice to your life published in the Current Colorectal Cancer Reports (2009); and The Division of Hematology/Oncology, Department of Internal Medicine and Comprehensive Cancer Center, University of Michigan used Sabinsas Curcumin C3 Complexand BioPerine® combination in a clinical trial aimed at reducing stem cell number and inhibiting its self-renewal as part of their treatment protocols: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.



Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like